Proton Data
Hello, does anyone know where I might get my hands on an exome dataset from the Proton?
-
-
Did you ask your Ion salesperson? They usually have example data sets to share with customers... -
Yes I am in the process of getting some data from LifeTech but you'd imagine that they are going to send me some pretty nice data and I want to see something 'real' too.Comment
-
We are also looking for a public dataset for months now, quite annoyed we can not see what is really going on here!Comment
-
to be clear, by exome, you mean DNA?Comment
-
yes DNA, Life are giving me some data but it's under a CDA agreement so I won't be able to discuss anything that I find.Comment
-
I've found them to be pretty good about sharing data. As with all new instruments, the vendors are careful about sharing new data... Besides working with the vendors, I have usually been able to get good example data early from Partek.Comment
-
In case you're still looking (or in case someone has the same issue later), you can search in the NIAID Data Ecosystem. It looks like there are relevant results if you just try "exome proton": https://data.niaid.nih.gov/search?q=...roton&filters=Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment